/ /

  • linkedin
  • Increase Font
  • Sharebar

    Zeiss broadens portfolio of IOLs


    Jena, Germany and Ontario, CA—Carl Zeiss Meditec AG has acquired—through its subsidiary Carl Zeiss Meditic Inc.—100% of the shares in Aaren Scientific Inc., a US-based manufacturer of IOLs.

    The majority of shares in Aaren Scientific had previously been owned by a private investment company, as well as other investors, including the chief executive officer and co-founding of the company, Rick Aguilera.

    Aguilera, along with Aaren Scientific’s entire management team, will stay on board after the transaction.

    “The two companies, Zeiss and Aaren Scientific, are highly complementary and enable Zeiss to offer ophthalmic surgeons a broader portfolio of solutions,” said Ludwin Monz, PhD, executive board member, president, and chief executive officer of Zeiss Meditec AG. “By giving our customers a wider range of IOL choices than any other company, we will be in a position to provide them with tailored solutions for their patients.”


    For more articles in this issue of Ophthalmology Times eReport, click here.



    To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

    Rose Schneider Krivich
    Rose is the content specialist for Medical Economics.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results